Tyra Biosciences Incorporated is a preclinical-stage biopharmaceutical company developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting other cancers. Tyra Biosciences was incorporated in 2018 and is headquartered in Carlsbad, CA.
What is Tyra Biosciences's quote symbol?
What is the 52 week high and low for Tyra Biosciences (NASDAQ: TYRA)?
How much is Tyra Biosciences stock worth today?
How much is Tyra Biosciences's stock price per share?
What is Tyra Biosciences's Market Cap?